What does space smell like? This perfume-making astrobiologist is trying to find out
After a long career of creating designer perfumes, Marina Barcenilla decided to turn her nose to the cosmos.
The fragrance designer enrolled in university in 2015 to study planetary science. She was taking classes in astrochemistry — the chemical makeup of outer space — when she realized she could marry her two passions.
"Whenever I see something new, the first question is: I wonder what that smells like," she told As It Happens host Nil Köksal.
"One day I thought: Actually, this molecule that I'm studying? I have it in my perfume lab. And this smell that I am imagining? I could actually create it."
Barcenilla is now an astrobiology doctoral researcher at the University of Westminster in London, England. When she's not exploring the feasibility of life on Mars, she's recreating the smells of space, from the sulfuric stench of Jupiter's deepest clouds, to the pungent alcohol-like punch at the centre of the Milky Way.
Four of those stellar scents are now available for public sniffing at the London Natural History Museum, as part of the ongoing exhibit: Space: Could life exist beyond Earth?
'Antiseptic,' but also like gunpowder?
So what does space smell like?
"I don't think it smells very good in general," said Barcenilla.
Those in the know can attest. Canadian astronaut Julie Payette, upon returning from the International Space Station, told CBC News in 2009 that space smells "cold" and "antiseptic."
"I opened the hatch six hours after the space walk. This entire airlock area had been exposed to the vacuum of space for all those hours. So when I opened the door, I smelled what was kind of an antiseptic smell," she said.
"It was not detergent but it was definitely like a hospital-smell type and I thought, 'Wow, that's the smell of space.' The more I thought about it, I thought: 'Wow, this is what nothing smells like, because there's probably nothing left in there, not a single microbe or anything.'"
Canadian astronaut Chris Hatfield, meanwhile, described it differently, noting in 2013 that he and many others aboard the station reported a "burnt steak and gunpowder" smell in the airlock.
"Not exactly a spring garden," he said in a Canadian Space Agency video.
Barcenilla says that when it comes to the smells of space, it really depends on what, specifically, you mean.
"Most of space is quite empty and … it isn't really going to smell," she said. "But it's when you get to specific planets or moons, or when you go to a molecular cloud where we find high concentrations of different gases and microscopic dust, that we can then find molecules and chemical compounds that have a smell."
Barcenilla says she's created 25 smells since she began doing this work in 2017.
For the museum exhibit, she whipped up the scent of Mars, which is her scientific specialty; Titan, a large moon orbiting the planet Saturn; Bennu, an asteroid; and Earth as it was some 3.5-4 billion years ago, when life was just beginning.
"The early Earth is a bit smelly. It's a combination of a little bit of kind of earthy wet smell, like what you get when it rains, but also with the smell that you get from various microbial strains," she said.
"One of the smells that you get is a kind of sulphury cabbagey smell that goes in there as well. So that's a bit stinky."
She admits that none of her creations can be fact-checked, per se.
"In space, you can't smell so it's always going to be impossible. We don't have air that we can breathe, so that's completely out of the question," she said. "But what I'm trying to do is recreate the chemistry that we find in various places in space."
'The more it stinks, the more people like to smell it'
Barcenilla has brought her space smells to schools to teach children, and she's also had a chance to watch people interact with them at the museum.
"I always thought people are going to be a bit scared about the smelly stuff, but no, those are the best ones," she said. "The more it stinks, the more people like to smell it and the more they laugh and the more questions they ask about it."
Triggering that curiosity, she says, is the whole point.
"It's about bringing space closer to Earth, and it's for people to open their minds and understand that everything that we have out there in space has also ended up here on Earth," she said.
As foreign as the final frontier may seem, Barcenilla says there's nothing out there that's truly unfamiliar, at least from an olfactory perspective.
Jupiter's inner clouds? Barcenilla tells BBC News they're full of ammonia and sulphur, something you might find in fertilizer, and which smells like rotten eggs.
The very centre of our galaxy? There you'll find Ethyl formate, a compound commonly found in fruit, and which probably smells, at best, like rum, and at worst, like nail polish remover.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CTV News
a day ago
- CTV News
Woman off insulin for Type 1 diabetes after a single dose of experimental manufactured stem cells
Amanda Smith celebrates the day, August 1, nearly two years ago, when she stopped taking insulin to manage her type one diabetes, just a few months after getting a dose of experimental stem cells as part of a study. 'I remember, like, being scared and excited, and it's history now,' she said. The 36-year-old nurse and mother is part of a small, but what some call 'milestone study,' of patients with Type 1 Diabetes using manufactured stem cells, designed to grow in the liver and become the full array of islet cells array of pancreatic islet cells that naturally control blood sugar levels. In a study published in the New England Journal of Medicine, researchers report that of the 12 patients who received a single dose of the stem cells, it eliminated the need for insulin in 10 for at least a year and stopped episodes of low blood sugar, or hypoglycemia, which can lead to dangerous complications, even death. For Amanda, the treatment has been a blessing. Diagnosed with late-onset juvenile diabetes when she was 25, she was plagued with sudden bouts of low blood sugar, or hypoglycemia that would leave her faint, despite close monitoring. The risk was a diabetic coma or worse. 'I get emotional because I'm free from those handcuffs ... I don't have that looming over me every day,' she said from her home in London, Ont. 'I took it as a death sentence,' she said. 'I knew, eventually, like the end is always some sort of complication with diabetes,' she said 'We've ... dealt with a lot of patients that have struggled with diabetes. And to be able to see such a transformational change in their life is just amazing,' said Dr. Trevor Reichman, the lead author and the Surgical Director of the Pancreas and Islet Cell Transplant Program at the University Health Network in Toronto. Dr. Trevor Reichman Dr. Trevor Reichman appears for an interview with CTV News. Reichman says it is the first time that scientists have seen this kind of response with implanted stem cell-derived islets. Vertex, a Boston-based biotech company that sponsored the study, derived the cells from embryonic tissue and then found a way to grow them stem cells in large quantities. Researchers, working at centers in the U.S. and at least three transplant hospitals in Canada, infused them into the patient's liver. Over the next four to six months, Reichman said they transformed into the array of hormone-producing cells found in a normal pancreas, and they were monitoring the patients' blood sugar levels in real time. 'In the liver, they're sensing a patient's blood glucose level, and they're secreting the appropriate hormone,' said Reichman. adding that these biological replacements appear to sense changes in 'seconds or milliseconds. Essentially, it's the same as your native islet cells would function.' 'I think the data is just so very exciting, so very, very powerful,' said Dr. Peter Senior, director of the Alberta Diabetes Institute at the University of Alberta. He was not part of this study. 'The primary objective of the study was just to show that the blood sugars were better and that people were not having severe hypoglycemia. They blew past that. Ten of the 12 people are off insulin,' said Senior. ' It's never been done before in history' said Dr. Michael Thompson, director of Vancouver General Diabetes Centre. 'It's first time they a have achieved a high enough levels of insulin in patients,'using a stem cell product 'It's a big advance' he added. But there's a tradeoff. The patients, however, require immune-suppressing drugs for life, so that the immune system doesn't destroy the cells. There are risks to these immunosuppressive medications, including a higher risk of some cancers, infections, and high blood pressure. Amanda says it is nothing like her constant terror that she might slip into a sudden diabetic coma. 'Taking a couple of pills three times a day is nothing. I take it with breakfast, lunch, and dinner. It's easy. No comparison, none,' she said. 'And I know it's a huge relief for my family, especially my husband, that's for sure.' The study also reports that two patients in the study died, one likely as a result of complications from that immunosuppression, which Dr. Reichman says underscores the need for patients to be closely monitored at experienced transplant centers. A second patient, according to the study, died of severe dementia. Off-the-shelf live cell therapy The idea of using cells implanted in the body to produce insulin, instead of insulin injections, began in Canada 25 years ago. Researchers in Alberta pioneered the Edmonton Protocol. It uses insulin-producing islet cells removed from diseased organ donors that are implanted into those with hard-to-manage Type 1 Diabetes. Some 2,500 patients have been treated around the world, according to the University of Alberta, which reports 80 per cent were able to stop taking insulin injections for a median time of 95 days. Stem cells pipettes (Image credit: Vertex) But the number of procedures is limited because there aren't enough organ donors to meet the demand, and patients also require long-term immune suppression. So, there have been some two dozen companies around the world looking at other ways of getting manufactured islet cells to regulate blood sugar as a replacement for insulin. The Vertex cells, originally called VX-880, have been renamed Zimislecel. The Boston-based pharmaceutical company (says it is ramping up production, as it 'These are fresh, brand-new cells – they're not 60-year-old cells that have already had a life, and we're repurposing them,' said Senior, who works in Edmonton. It pushes the boundary of therapy forward because there is the potential to create a renewable source of insulin-producing cells instead of waiting for cells from deceased donors,' he added. 'I think we've got a treatment for diabetes where we are no longer constrained by organ donors,' said Senior. 'We've got potentially a limitless source of cells that could be used, and that is a massively huge step forward in terms of a cell therapy becoming a reality.' The next step is for someone to produce stem cells that don't require immune suppression, by either genetically engineering the cells or encapsulating them to make them invisible to immune attack. Several pilot studies are underway. It's a welcome advance, according to Senior. While insulin therapy has been a lifesaver for many since its discovery in Toronto by Banting and Best in 1921, it's never been a cure. Stem Cells (Image credit: Vertex) 'I think people with diabetes deserve some of the transformative treatments we've seen in cancer and other diseases but we've been stuck essentially doing the same thing for 100 years,' said Senior. In Canada, there are some 300000 people with Type 1 diabetes. Thirty-two new cases are diagnosed each day. The number of new cases per year increased by 34 per cent between 2000 and 2022, according to Breakthrough TD1(formerly the Juvenile Diabetes Foundation of Canada). Unlike Type 2 diabetes, which is linked to environmental, dietary, and genetic factors, the exact cause of Type 1 diabetes is still unknown, but doctors say the immune system mistakenly attacks insulin-producing islet cells in the pancreas, resulting in a gradual decline in the availability of insulin to regulate blood sugar. Questions remain The study is being continued to include a total of 50 patients, in Vancouver, Edmonton, Toronto and the U.S., with Dr. Reichman's team actively recruiting candidates. There are still many questions. Dr. Reichman admits that no one knows how long these implanted cells will last. Amanda hasn't required any insulin inections for almost two years, the longest documented period so far. He adds there are no signs that the other nine, who also went off insulin, have gone back on the injections since their stem cell infusion. Unclear also is whether this therapy will reduce the longer-term and burdensome complications of diabetes, including heart problems, amputations, kidney failure, and vision loss. However, data from patients treated with the Edmonton protocol, using tissue from deceased donors, show signs of reduced complications, a promising sign for the newer therapy, according to Dr. Thompson. The other concern is that not all patients with severe hypoglycemia may want to make the same choice as Amanda, swapping the diabetes risks for those that come with the anti-rejection medications. 'Taking a couple of pills three times a day is nothing. It's easy. There's no comparison, none,' she said. Another question is that a single treatment therapy for this disease could come with a very high price tag. 'We'll have to wait and see,' said Reichman. Amanda Smith, meanwhile, tries to enjoy her freedom with her family and her work at a long-term care home, without thinking too far ahead. 'What happens if the cells stop working or something? You know, I just try and live right now, and I feel so blessed.' She debates the question - does she have diabetes anymore? 'I don't take any insulin anymore. I don't take medication for diabetes anymore. So, I feel like a regular person again without diabetes.'
National Post
a day ago
- National Post
What we know about yawning, from why we do it to why it's contagious
Yawning is strange. Article content It's not obviously just mechanical, like a burp to release gas pressure, or just psychological, like a yelp to express fear or excitement. A yawn is more like a sneeze or a hiccup, an involuntary breath event that is sometimes more or less resistible. Article content Article content But what is really strange, almost unique among human behaviours, is that yawning is contagious. Article content New research on chimpanzees by a British team of cognitive scientists shows contagious yawning is not only common in other species, and can happen between species, but that it can also be induced in chimps by an obviously artificial humanoid robot, an android 'agent' that is just a creepy looking disembodied head and shoulders, and which doesn't even breathe, but which can still give a believable facsimile of a yawn. Article content Article content The paper, published this month in Nature Scientific Reports, details an experiment in which the chimps were shown three behaviours by the android: a full wide-mouth yawn, a more moderate gaping mouth, and a closed mouth. Article content 'The results showed that adult chimpanzees exhibited across-agent yawn contagion, with a graded response: the highest contagion occurred when the android displayed a fully wide-open mouth (Yawn condition), a reduced response when the mouth was partially opened (Gape condition), and no contagion when the android's mouth was closed,' the paper says. Article content Article content And the chimps did not only yawn in response to the yawning robot. They also 'engaged in behaviours associated with drowsiness,' basically by preparing a comfortable place to lie down. Article content Article content 'This suggests that yawning by an unfamiliar model may act as a contextual cue for rest, rather than merely triggering a motor resonance response,' the paper says. Article content Diverse species exhibit contagious yawning, certainly mammals like dogs and cats, but even fish, whose respiratory system shares evolutionary origins with our own. Article content Most vertebrates yawn, but those that are known to yawn contagiously are usually pack animals, somehow social. This suggests the evolutionary purpose of the yawn is at least partly at the level of the group, not just the individual. A sneeze just tries to blast stuff out of your nose, a burp just lets gas out of your belly, but a yawn means something to other people. Article content Not always, of course, Yawning might, for example, help cool the brain for optimal performance, as one theory holds. But yawning also involves empathy, as its contagious aspect shows. It is a social phenomenon, and catching, like laughter. Article content 'What I find strange is that if we see someone walking, we don't an feel urge to walk. But with yawning, we do,' said Ramiro Joly-Mascheroni, a research fellow in social and cognitive neuroscience at City St. George's University of London in the U.K., in an interview.
CTV News
a day ago
- CTV News
U.K. warning reignites concerns over using weight-loss drugs while on birth control
A recent warning from the United Kingdom's drug regulator has renewed questions about whether popular weight-loss and diabetes medications could reduce the effectiveness of hormonal birth control. The U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) issued an alert on June 5 about pregnancies among users of medications such as Ozempic, Wegovy and Mounjaro, sometimes referred to as 'skinny jabs.' 'Women taking popular medicines for weight loss and diabetes… are being reminded to use effective contraception while taking these medicines,' the guidance said. Ozempic and Wegovy, which both contain semaglutide, and Mounjaro, which contains tirzepatide, are part of a class of medications known as GLP-1 receptor agonists. These drugs mimic gut hormones to increase insulin production, slow digestion and suppress appetite. 'These medications delay the absorption of food, so they may also delay or reduce the absorption of the birth control pill,' Dr. Togas Tulandi, chief of obstetrics and gynecology at McGill University Health Centre said in a video interview with CTV Tulandi noted that non-oral methods, such as intrauterine devices (IUDs) or implants, are not affected by weight-loss drugs and remain effective. The MHRA also advises people using the pill to use a barrier method, such as condoms- , reiterating that these medications should not be taken during pregnancy, while trying to conceive or while breastfeeding, due to limited safety data. 'Anyone who gets pregnant while using them should speak to their healthcare professional and stop the medicine as soon as possible,' the MHRA said. Although this is the first formal warning of its kind in the U.K., the issue has been circulating in online communities and medical circles. Some women shared surprise emergencies on platforms like TikTok and Reddit using the hashtag #OzempicBaby — with some saying it happened despite using the pill, and others linking increased fertility to weight loss or improved hormone regulation. While widely promoted online for weight loss, not all GLP-1 drugs are approved for that use. In Canada, Ozempic and Mounjaro are approved for Type 2 diabetes in adults with obesity or related conditions, and Wegovy for weight management. Health Canada told CTV in a statement that the U.K.'s alert is consistent with existing guidance in Canada. 'All Canadian product monographs for GLP-1 receptor agonists advise against using these drugs during pregnancy, and many include warnings about potential interactions with oral contraceptives,' it said. Health Canada says it continues to monitor the safety of health products and will take action if new issues arise. Novo Nordisk, the maker of Ozempic and Wegovy, says no clinically relevant interactions have been found between semaglutide and oral contraceptives containing ethinylestradiol and levonorgestrel. However, the company still recommends patients discontinue use if they become pregnant or plan to conceive. 'Patient safety is a top priority for Novo Nordisk, and we work closely with authorities and regulatory bodies worldwide to continuously monitor the safety and efficacy of our products,' company spokesperson Marie-Pier Burelle said in a statement to Tulandi advises people hoping to conceive to ideally focus on weight loss first, then stop the medication and try to become pregnant. He also pointed to a lesser-known safety issue. 'If you're taking this type of medication and you're undergoing surgery, you should stop it at least two weeks before, because (while you take these medications) food absorption is delayed and when you undergo surgery, the food might still be in the stomach,' he said. Failing to pause the medication could increase the risk of aspiration, where food enters the lungs. He said some patients have had surgeries cancelled as a result.
